Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
402.74M | 389.29M | 252.30M | 267.00M | 160.50M | Gross Profit |
167.22M | 153.31M | 105.70M | 135.00M | 82.80M | EBIT |
95.59M | 90.73M | 103.11M | 94.50M | 68.41M | EBITDA |
178.32M | 129.51M | 84.36M | 112.66M | 57.87M | Net Income Common Stockholders |
74.19M | 77.71M | 70.93M | 74.55M | 45.20M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
88.76M | 86.07M | 78.30M | 159.20M | 154.90M | Total Assets |
1.54B | 1.52B | 1.43B | 1.21B | 1.04B | Total Debt |
621.01M | 632.89M | 563.80M | 400.60M | 336.20M | Net Debt |
532.25M | 546.83M | 526.10M | 330.40M | 229.40M | Total Liabilities |
801.84M | 825.04M | 779.70M | 582.10M | 469.10M | Stockholders Equity |
724.28M | 683.06M | 651.10M | 626.10M | 568.20M |
Cash Flow | Free Cash Flow | |||
58.06M | -36.12M | -210.94M | -41.70M | -84.44M | Operating Cash Flow |
107.99M | 103.85M | 48.22M | 111.80M | 37.33M | Investing Cash Flow |
-50.38M | -99.14M | -189.78M | -196.09M | -164.50M | Financing Cash Flow |
-52.07M | 40.76M | 112.46M | 48.57M | 48.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $5.86B | 6.95 | 15.80% | ― | 10.11% | 19.06% | |
71 Outperform | $569.07M | 5.49 | 9.58% | ― | 12.37% | 50.04% | |
69 Neutral | $10.47B | 7.25 | 20.38% | 0.94% | 5.86% | 12.20% | |
68 Neutral | $30.08B | 8.34 | 14.99% | 1.85% | 2.06% | -3.67% | |
67 Neutral | $2.63B | 35.49 | 10.54% | 1.20% | 3.46% | -4.56% | |
66 Neutral | $1.04B | 5.77 | 12.04% | ― | -4.72% | -2.38% | |
61 Neutral | $4.72B | 17.64 | -3.07% | 10.89% | 5.99% | -21.86% |
The St. Joe Company announced significant leadership changes with Bruce Berkowitz retiring as Chairman and Jorge L. Gonzalez stepping in, alongside Rhea Goff’s appointment as a non-independent director. The company reported a 2% dip in total revenue for Q3 2024, despite a 17% rise in hospitality and 19% increase in leasing revenues. Real estate revenue fell by 32% due to varying sales timing and product mix. The firm continues to see strong demand, with over 22,000 homesites in development, and plans for an expanding medical campus, which promises to enhance regional healthcare and economic growth.